Lupin Launches Smart Device for Metered-Dose Inhalers to Support Treatment of Respiratory Diseases in India

 Lupin Launches Smart Device for Metered-Dose Inhalers to Support Treatment of Respiratory Diseases in India

Lupin Launches Smart Device for Metered-Dose Inhalers to Support Treatment of Respiratory Diseases in India

Shots:

  • Lupin in collaboration with Aptar Pharma launch ADHERO, a smart device designed to help patients with chronic respiratory diseases by tracking MDI usage thus facilitate adherence to the therapy
  • The launch will help patients utilizing MDI and HCPs to track adherence and compliance to therapy via patient’s dashboard as well as the app, thus lead to an improvement in clinical outcomes and QoL of patients
  • ADHERO is a Bluetooth-enabled, reusable smart device, which patients can access by connecting their devices to the “MyAdhero” app on their smartphones. The app sends reminders, provide health alerts based on AQI at the patient’s current location and enable visual analytics

Click here to­ read full press release/ article | Ref: Lupin | Image: Pinterest

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post